Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis

Abstract

Summary Background Increasing access to hepatitis C virus (HCV) care and treatment will require simplified service delivery models. We aimed to evaluate the effects of decentralisation and integration of testing, care, and treatment with harm-reduction and other services, and task-shifting to non-specialists on outcomes across the HCV care continuum. Methods For this systematic review and meta-analysis, we searched PubMed, Embase, WHO Global Index Medicus, and conference abstracts for studies published between Jan 1, 2008, and Feb 20, 2018, that evaluated uptake of HCV testing, linkage to care, treatment, cure assessment, and sustained virological response at 12 weeks (SVR12) in people who inject drugs, people in prisons, people living with HIV, and the general population. Randomised controlled trials, non-randomised studies, and observational studies were eligible for inclusion. Studies with a sample size of ten or less for the largest denominator were excluded. Studies were categorised according to the level of decentralisation: full (testing and treatment at same site), partial (testing at decentralised site and referral elsewhere for treatment), or none. Task-shifting was categorised as treatment by specialists or non-specialists. Data on outcomes across the HCV care continuum (linkage to care, treatment uptake, and SVR12) were pooled using random-effects meta-analysis. Findings Our search identified 8050 reports, of which 132 met the eligibility criteria, and an additional ten reports were identified from reference citations and grey literature. Therefore, the final synthesis included 142 studies from 34 countries (20 [14%] studies from low-income and middle-income countries) and a total of 489 996 patients (239 446 [49%] from low-income and middle-income countries). Rates of linkage to care were higher with full decentralisation compared with partial or no decentralisation among people who inject drugs (full 72% [95% CI 57–85] vs partial 53% [38–67] vs none 47% [11–84]) and among people in prisons (full 94% [79–100] vs partial 50% [29–71]), although the CIs overlap for people who inject drugs. Similarly, treatment uptake was higher with full decentralisation compared with partial or no decentralisation (people who inject drugs: full 73% [65–80] vs partial 66% [55–77] vs none 35% [23–48]; people in prisons: full 72% [48–91] vs partial 39% [17–63]), although CIs overlap for full versus partial decentralisation. The results in the general population studies were more heterogeneous. SVR12 rates were high (≥90%) across different levels of decentralisation in all populations. Task-shifting of care and treatment to a non-specialist was associated with similar SVR12 rates to treatment delivered by specialists. There was a severe or critical risk of bias for 46% of studi...

Regional progress towards hepatitis C elimination in the Western Pacific Region, 2015-2020

“…A multi-dimensional, public health approach for prevention and treatment of viral hepatitis and chronic liver disease alongside addressing harmful use of alcohol and obesity (non-alcoholic fatty liver disease, NAFLD) is also required (45). There is need to strengthen national responses in access to hepatitis testing and care and achieve more systematic testing of the adults, adolescents and children in high-burden countries or high priority populations, ensure screening for liver cancer particularly among those with cirrhosis even following cure, simplify models of care and delivery, deliver decentralized and integrated services at primary care, task-shift routine care to non-specialists, and promote HCV-self testing use and multiplex rapid diagnostics in different population groups, as well as strategic placement of point-of-care HCV viral load platforms (11,(46)(47)(48)(49). Increasing use of pooled procurement will also be important to reduce costs of tests and medicines, as well as improved governance over existing data systems to enable better reporting to the Global Reporting Systems for Hepatitis (GRSH) (50).…”

“…There are even greater opportunities for simplification with HCV infection, as short course curative treatment requires minimal expertise and monitoring. A recent comprehensive WHO-led systematic review of 142 studies now provides a strong evidence-base supporting these approaches in HCV care (11). Full decentralization of HCV testing and treatment at the same site compared to no or only partial decentralization was associated with increased linkage and treatment uptake, especially among persons who inject drugs.…”

Usability and Acceptability of Oral-Based HCV Self-Testing Among Key Populations: A Mixed-Methods Evaluation in Tbilisi, Georgia

“…A previous study conducted among PWID and MSM in London also identi ed participants concerns about access to con rmatory testing and linkage to care and treatment [29]. Although innovations in diagnostics such as HCVST can contribute to bridging the gap in diagnosis, simpli ed and decentralised models of care are also urgently needed to achieve elimination targets [43,44].…”

What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review

“…Fully committing to elimination requires investment in identifying the infections, and access to treatment alone is not sufficient to eliminate hepatitis C. The effectiveness of the screening, diagnosis and treatment strategies to identify the infections is a critical determinant of the speed at which elimination can be realized. There have been recommendations made by the professional liver study society and the WHO for countries to simplify the algorithm of hepatitis C diagnostic & treatment [39] , [40] , [41] , [42] , [43] . Simpler and innovative models of care must be established for a scale-up of treatment [44] .…”